{"transactions":[{"id":2639896,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":137534,"kind":"person","name":"Bregman Marc","position":1,"cik":"0001863113","reported_name":"Bregman Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Options","published_at":"2021-07-07T21:00:33.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":300000,"price":0.0562,"value":16860.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022"}],"balance_after":300000,"derivative":{"exercise_price":0.0562,"exercise_date":"2022-05-17","expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001863113-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000186311321000002/primary_doc.xml","form_type":"4"}}]}